Hair regrowth: Therapeutic agents

Dermatologic Clinics

Volumn 16, Issue 2, 1998, Pages 341-356

  Shapiro, J ^a   Price, V H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; DITHRANOL; FINASTERIDE; MINOXIDIL; RETINOIC ACID; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE;

ALOPECIA AREATA; CLINICAL PRACTICE; DISEASE CLASSIFICATION; GROWTH RATE; HAIR GROWTH; HAIR LOSS; HUMAN; IMMUNOMODULATION; MALE TYPE ALOPECIA; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0031897961     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70017-6     Document Type: Article

References (117)

1. H. Baden J. Kubilus Effect of minoxidil on cultured keratinocytes J Invest Dermatol 81 1983 558
2. J. Barth C. Darley J. Gibson Squaric acid dibutylester in the treatment of alopecia areata Dermatologica 170 1985 40
3. G. Bazzano N. Terezakis W. Galen Topical tretinoin for hair growth promotion J Am Acad Dermatol 15 1986 880
4. K. Bingham D. Shaw The metabolism of testosterone by human male scalp skin J Endocrinol 57 1973 111
5. A. Buhl Minoxidil's action in hair follicles J Invest Dermatol 96 1991 73S 74S
6. A. Buhl D. Waldon T. Kawabe Minoxidil stimulates mouse vibrissae follicles in organ culture J Invest Dermatol 84 1985 358
7. B. Burke W. Cunliffe Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia Br J Dermatol 112 1985 124
8. P. Case A. Mitchell N. Swanson Topical therapy of alopecia areata with squaric acid dibutyl ester J Am Acad Dermatol 10 1984 447
9. R. Casserio Treatment of alopecia areata with squaric acid dibutylester Arch Dermatol 123 1987 1037
10. W. Chen C. Zouboulis C. Orfanos The 5α-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders Dermatology 193 1996 177
11. F. Chytil Retinoic acid: Biochemistry and metabolism J Am Acad Dermatol 15 1986 741
12. P. Corvol Antiandrogenic effect of spironolactones: Mechanism of action Endocrinology 97 1975 52
13. R. Coskey L. Drake M. Hordinsky Guidelines of care for alopecia areata J Am Acad Dermatol 26 1992 247
14. A. Dallob N. Sadick W. Unger The effect of finasteride, a 5α reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness J Clin Endocrinol Metab 79 1994 703
15. L. Daman W. Rosenberg L. Drake Treatment of alopecia areata with dinitrochlorobenzene Arch Dermatol 114 1978 1629
16. R.P.R. Dawber T. Sonnex I. Ralfs Oral antiandrogen treatment of common baldness in women Br J Dermatol 107 suppl 22 1982 20
17. Y. Deproste C. Paquez R. Tourraine Dinitrochlorobenzene treatment of alopecia areata Arch Dermatol 118 1982 542
18. R. DeVillez J. Jacobs C. Szpunar Androgenetic alopecia in the female: Treatment with 2% minoxidil solution Arch Dermatol 130 1994 303
19. A. Diani Hair growth effects of oral administration of finasteride, a steroid 5 alpha reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque J Clin Endocrinol Metab 74 1992 345
20. J. Ekoe P. Burckhardt B. Ruedi Treatment of hirsutism, acne and alopecia with cyproterone acetate Dermatologica 160 1980 398
21. P. Elias Epidermal effects of retinoids: Supramolecular observations and clinical implications J Am Acad Dermatol 15 1986 797
22. V. Fiedler Alopecia areata: Current therapy J Invest Dermatol 96 1991 69S
23. V. Fiedler-Weiss C. Buys Evaluation of anthralin in the treatment of alopecia areata Arch Dermatol 1233 1987 1491
24. V. Fiedler-Weiss D. West C. Buys Topical minoxidil dose response effect in alopecia areata Arch Dermatol 122 1986 180
25. K. Gill D. Baxter Alopecia totalis—treatment with fluocinolone acetonide Arch Dermatol 87 1963 384
26. G. Gormley E. Stoner R. Bruskewitz The effect of finasteride in men with benign prostatic hyperplasia N Engl J Med 327 1992 1185
27. J.B. Hamilton Patterned loss of hair in man: Types and incidence Ann NY Acad Sci 53 1951 708
28. J. Hammerstein Use of cyproterone acetate in the treatment of acne, hirsutism and virilism J Steroid Biochem Mol Biol 6 1975 827
29. R. Happle Antigenic competition as a therapeutic concept for alopecia areata Arch Dermatol Res 26 1981 285
30. R. Happle Topical immunotherapy in alopecia areata J Invest Dermatol 96 1991 71S
31. R. Happle B. Hausen L. Wiesner-Menzel Diphency-prone in the treatment of alopecia areata Acta Derm Venereol Suppl (Stockh) 63 1983 49
32. R. Happle K. Kalveran U. Buchner Contact allergy as a therapeutic tool for alopecia areata: Application of squaric acid dibutylester Dermatologica 161 1980 289
33. E. Healy S. Rogers PUVA treatment for alopecia areata—does it work? A retrospective review of 102 cases Br J Dermatol 129 1993 42
34. J. Imperato-McGinley L. Guerrero Steroid 5 alpha reductase deficiency in man: An inherited form of male pseudohermaphroditism Science 186 1974 1213
35. J. Imperato-McGinley 5 α-reductase deficiency Curr Ther Endocrinol Metab 5 1994 351
36. S. Itami S. Kurata T. Sonoda Mechanism of action of androgen in dermal papilla cells Ann NY Acad Sci 642 1991 385
37. S. Itami S. Kurata T. Sonoda Characterization of 5 α-reductase in cultured human dermal papilla cells from beard and occipital hair J Invest Dermatol 96 1991 57
38. J. Kassimir Use of topical minoxidil as a possible adjunct to hair transplant surgery J Am Acad Dermatol 16 1987 685
39. K. Kaufman Androgen metabolism as it affects hair growth in androgenetic alopecia Dermatol Clin 14 1996 697
40. K. Kaufman Clinical studies on the effects of oral finasteride, a type II 5α-reductase inhibitor, on scalp hair in men with male pattern baldness D. Van Neste V. Randall Hair Research for the Next Millenium 1996 Elsevier Science Amsterdam 363
41. K. Kaufman Treatment with finasteride 1 mg per day in men with male pattern hair loss Australas J Dermatol 38 1997 20
42. F. Kiesewetter P. Langer H. Schell Minoxidil stimulates mouse vibrissae follicles in organ culture [letter] J Invest Dermatol 96 1991 295
43. E. Khoury V. Price M.M. Abdel-Salam Topical minoxidil in alopecia areata: No effect on the perifollicular lymphoid infiltration J Invest Dermatol 99 1992 40
44. W. Kuster Happle The inheritance of common baldness: Two B or not two B? J Am Acad Dermatol 1984 921
45. A. Lassus U. Kianto E. Johansson PUVA treatment for alopecia areata Dermatologica 161 1980 298
46. J. Leyden A. Kligman Treatment of alopecia areata with steroid solution Arch Dermatol 106 1972 924
47. R.A. Lobo The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women Fertil Steril 43 1985 200
48. D. Loriaux Spironolactone and endocrine dysfunction (NIH conference) Ann Intern Med 85 1976 630
49. E. Ludwig Classification of the types of androgenetic alopecia occurring in the female sex Br J Dermatol 97 1977 247
50. S. MacDonald-Hull L. Pepall W. Cunliffe Alopecia areata in children: Response to treatment with diphencyprone Br J Dermatol 125 1991 164
51. S. MacDonald-Hull W. Cunliffe Successful treatment of alopecia areata using the contact allergen diphencyprone Br J Dermatol 124 1991 212
52. S. MacDonald-Hull J. Norris Diphencyprone in the treatment of longstanding alopecia areata Br J Dermatol 119 1988 367
53. R. Menard T. Guenthner H. Kon Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone J Biol Chem 254 1979 1726
54. L. Montes Topical halcinonide in alopecia areata and alopecia totalis J Cutan Pathol 4 1977 47
55. V. Morhenn E. Orenberg J. Kaplan Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis J Invest Dermatol 81 1983 23
56. C. Mortimer H. Rushton K. James Effective medical treatment for common baldness in women Clin Exp Dermatol 9 1984 342
57. M. Namer Clinical applications of antiandrogens J Steroid Biochem Mol Biol 31 1988 719
58. F. Neumann Pharmacology and potential use of cyproterone acetate Horm Metab Res 9 1977 1
59. O.T. Norwood Male pattern baldness: Classification and incidence South Med J 68 1975 1359
60. M. Ohtsuyama M. Morhashi Minoxidil sulfate effect on internal calcium of cell in the epidermis and epidermal appendages D. Van Neste V. Randall Hair Research for the Next Millenium 1996 Elsevier Science Amsterdam 481
61. E. Olsen Treatment of androgenetic alopecia with topical minoxidil Res Staff Phys 35 1989 53
62. E. Olsen Androgenetic alopecia E. Olsen Disorders of Hair Growth 1994 McGraw-Hill, Inc. New York 257
63. E. Olsen E. DeLong M. Weiner Long-term follow-up of men with male pattern baldness treated with topical minoxidil J Am Acad Dermatol 16 1987 688
64. E. Olsen M.S. Weiner I. Amara Five year follow up of men with androgenetic alopecia treated with topical minoxidil J Am Acad Dermatol 22 1990 643
65. E. Olsen M.S. Weiner Topical minoxidil in male pattern hair loss: Effects of discontinuation of treatment J Am Acad Dermatol 17 1987 97
66. E. Olsen E. Delong M. Weiner Dose response study of topical minoxidil in male pattern baldness J Am Acad Dermatol 15 1986 30
67. E. Olsen S. Carson E. Turney Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata Arch Dermatol 128 1992 1467
68. G. Orecchia P. Malagoli L. Santagostino Treatment of severe alopecia areata Pediatr Dermatol 11 1994 65
69. C. Orfanos L. Vogels Lokaltherapie der alopecia androgenetica mit 17 alpha oestradiol Dermatologica 161 1980 124
70. M. Philpott D. Sanders T. Kealy Whole follicular culture Dermatol Clin 14 1996 595
71. V.H. Price H. Baden R. DeVillez Guidelines of care for androgenetic alopecia J Am Acad Dermatol 35 1996 465
72. V.H. Price Testosterone metabolism in the skin: A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens Arch Dermatol 111 1975 1496
73. V.H. Price Androgenetic alopecia and hair growth promotion R. DeVillez Androgenetic alopecia from empiricism to knowledge. Clin Dermatol 6 1988 218
74. V.H. Price E. Menefee Quantitative estimation of hair growth: Comparative changes in weight and hair count with 5% and 2% minoxidil, placebo and no treatment D. Van Neste V. Randall Hair Research for the Next Millenium 1996 Elsevier Science Amsterdam 67
75. V.H. Price Symposium on Rogaine (topical minoxidil 2%) in the management of male pattern baldness and alopecia areata: Summary J Am Acad Dermatol 16 1987 749
76. V.H. Price Topical minoxidil in extensive alopecia areata Dermatologica 175 suppl 2 1987 36
77. V.H. Price E. Khoury Progress in dermatology Bull Dermatol Found 25 1991 1
78. V.H. Price Double blind, placebo controlled evaluation of topical minoxidil in extensive alopecia areata J Am Acad Dermatol 16 1987 730
79. V.H. Price Topical minoxidil 3% in extensive alopecia areata including long term efficacy J Am Acad Dermatol 16 1987 737
80. V.H. Price Topical minoxidil in extensive alopecia areata, including 3 year follow-up Dermatologica 175 1987 36
81. V. Randall The use of dermal papilla cells in studies of normal and abnormal hair follicle biology Dermatol Clin 4 1996 585
82. V. Randall J. Thornton K. Hamada Mechanism of androgen action in cultured dermal papilla cells derived from human hair follicles with varying responses to androgens in vivo J Invest Dermatol 98 1992 86S
83. V.A. Randall M.J. Thornton A. Messenger Cultured dermal papilla cells from androgen-dependent human hair follicles contain more androgen receptors than those from non-balding areas of scalp J Endocrinol 133 1992 141
84. K. Ree Reduction of Langerhans cells in human epidermis during PUVA therapy: A morphometric study J Invest Dermatol 78 1982 488
85. D. Rushton Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia Journal Society of Cosmetic Chemists 42 1991 317
86. R. Savin A. Atton Minoxidil: Update on its clinical role Dermatol Clin 11 1993 55
87. M.E. Sawaya Purification of androgen receptors in human sebocytes and hair J Invest Dermatol 98 1992 92S
88. M.E. Sawaya V.H. Price K. Harris Human hair follicle aromatase activity in females with androgenetic alopecia [abstract] J Invest Dermatol 94 1990 575
89. M.E. Sawaya A. Mendez L. Lewis Two forms of androgen receptor protein in human hair follicles and sebaceous glands: Variation in transitional and bald scalp J Invest Dermatol 90 1988 606
90. M.E. Sawaya Steroid chemistry and hormone controls during the hair follicle cycle Ann NY Acad Sci 642 1991 376
91. M.E. Sawaya V.H. Price Different levels of 5 α-reductase type 1 and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia J Invest Dermatol 109 1997 296
92. M.E. Sawaya M.K. Hordinsky Glucocorticoid regulation of hair growth in alopecia areata J Invest Dermatol 194 suppl 5 1995 30S
93. J. Shaw Antiandrogen and hormonal treatment of acne Dermatol Clin 14 1996 803
94. J. Shapiro Alopecia areata Dermatol Clin 11 1993 35
95. J. Shapiro Topical immunotherapy in the treatment of chronic severe alopecia areata Dermatol Clin 11 1993 611
96. Shapiro J, MacDonald N, Lui H: Topical immunotherapy with diphencyprone for alopecia areata: The Vancouver seven year experience (in preparation)
97. N. Simpson The management of androgenetic alopecia in women J Dermatol Treatment 1 1989 107
98. M. Sporn A. Roberts N. Roche Mechanism of action of retinoids J Am Acad Dermatol 15 1986 756
99. R. Stern K. Nichols L. Vakeva Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet light A radiation (PUVA) N Engl J Med 236 1997 1041
100. E. Stoner The clinical development of 5 α-reductase inhibitor, finasteride J Steroid Biochem Mol Biol 37 1990 375
101. K. Summer W. Goggelman 1-Chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in the Salmonella typhimurium Mutat Res 77 1980 91
102. J. Sundelin C. Busch K. Das Structure and tissue distribution of some retinoid-binding proteins J Invest Dermatol 81 1983 59S
103. C. Taylor J. Hawk PUVA treatment of alopecia areata, partialis totalis and universalis: Audit of 10 years experience at St. Johns Institute Br J Dermatol 133 1995 914
104. R. Tremblay Treatment of hirsutism with spironolactone Clin Endocrinol Metab 15 1986 363
105. A. Tosti M. Guidetti F. Bardazzi Long term results of topical immunotherapy in children with alopecia totalis or alopecia universalis J Am Acad Dermatol 35 1996 199
106. H. Uno A. Cappas P. Bringham Action of topical minoxidil in the stump-tailed macaque J Am Acad Dermatol 16 1987 657
107. H. Uno A. Cappas C. Schlagel Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of the stumptailed macaques Am J Dermatopathol 7 1985 283
108. P. Van der Steen H. Van Baar R. Happle Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone J Am Acad Dermatol 24 1991 227
109. Van der Steen P. Van Baar H. C. Perret Treatment of alopecia areata with diphenylcyclopropenone J Am Acad Dermatol 24 1991 253
110. Van der Steen R. Happle Dyschromia in confetti as a side effect of topical immunotherapy with topical diphenylcyclopropenone Arch Dermatol 128 1992 518
111. J. Waldstreicher The effects of finasteride in men with frontal male pattern hair loss Australas J Dermatol 38 1997 101
112. E. Weisburger A. Russfield F. Homburger Testing of twenty one environmental aromatic amines or derivatives for long term toxicity or carcinogenicity J Environ Pathol Toxicol Oncol 2 1978 325
113. D. Whiting The treatment of alopecia areata Cutis 40 1987 248
114. M. Wilkerson J. Henkin J. Wilkin Diphenylcyclopropenone: Examination for potential contaminants, mechanisms of sensitization and photochemical stability J Am Acad Dermatol 11 1984 802
115. M. Wilkerson T. Connor J. Henkin Assessment of diphenylcyclopropenone for photochemical induced mutagenicity in the Ames assay J Am Acad Dermatol 17 1987 606
116. R. Winter F. Kern R. Blizzard Prednisone therapy for alopecia areata Arch Dermatol 112 1976 1549
117. C. Ziller Pattern formation in neural crest derivatives D. Van Neste Randall Hair Research for the Next Millenium 1996 Elsevier Science Amsterdam 1